Fused cyclic compounds and medicinal use thereof
OwnerHiromasa Hashimoto, Kenji Mizutani +1inventors
InventorsHiromasa Hashimoto, Kenji Mizutani, Atsuhito Yoshida
Life of this patent
Estimating the term…
Abstract
The present invention provides a fused ring compound of the following formula [I] 1 wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound of the present invention shows an anti-hapatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.
Claims87
A therapeutic agent for hepatitis C, which comprises a fused ring compound of the following formula [I] or a pharmaceutically acceptable salt thereof as an active ingredient:
- 1372
- wherein
- a broken line is a single bond or a double bond,
- G1 is C(—R1) or a nitrogen atom,
- G2 is C(—R2) or a nitrogen atom,
- G3 is C(—R3) or a nitrogen atom,
- G4 is C(—R4) or a nitrogen atom,
- G5, G6, G8 and G9 are each independently a carbon atom or a nitrogen atom,
- G7 is C(—R 7), an oxygen atom, a sulfur atom, or a nitrogen atom optionally substituted by R8,
- wherein R1, R2, R3 and R4 are each independently,
- (1) hydrogen atom,
- (2) C1-6 alkanoyl,
- (3) carboxyl,
- (4) cyano,
- (5) nitro,
- (6) C1-6 alkyl optionally substituted by 1 to 3 substituent(s) selected from the following group A, group A;
- halogen atom, hydroxyl group, carboxyl, amino, C1-6 alkoxy, C1-6 alkoxy C1-6 alkoxy, C1-6 alkoxycarbonyl and C1-6 alkylamino,
- (7) —COORa1
- wherein Ra1 is optionally substituted C1-6 alkyl (as defined above), C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the following group B or glucuronic acid residue, group B;
- halogen atom, cyano, nitro, C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkanoyl, —(CH2)r—COORb1, —(CH2)r—CONRb1Rb2, —(CH2)r—NRb1Rb2, —(CH2)r—NRb1—CORb2, —(CH2)r—NHSO2Rb1, —(CH2)r—ORb1, —(CH2)r—SRb1, —(CH2)r—SO2Rb1 and —(CH2)r—SO2NRb1Rb2 wherein Rb1 and Rb2 are each independently hydrogen atom or C1-6 alkyl and r is 0 or an integer of 1 to 6,
- (8) —CONRa2Ra3
- wherein Ra2 and Ra3 are each independently hydrogen atom, C1-6 alkoxy or optionally substituted C1-6 alkyl (as defined above),
- (9) —C(═NRa4 )NH2
- wherein Ra4 is hydrogen atom or hydroxyl group,
- (10) —NHRa5
- wherein Ra5 is hydrogen atom, C1-6 alkanoyl or C1-6 alkylsulfonyl,
- (11) —ORa6
- wherein Ra6 is hydrogen atom or optionally substituted C1-6 alkyl(as defined above),
- (12) —SO2Ra7
- wherein Ra7 is hydroxyl group, amino, C1-6 alkyl or C1-6 alkylamino,
- (13) —P(═O)(ORa31)2
- wherein Ra31 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above) or C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B or
- (14) heterocyclic group having 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom, and
- R7 and R8 are each hydrogen atom or optionally substituted C1-6 alkyl (as defined above),
- ring Cy is
- (1) C3-8 cycloalkyl optionally substituted by 1 to 5 substituent(s) selected from the following group C, group C;
- hydroxyl group, halogen atom, C1-6 alkyl and C1-6 alkoxy,
- wherein Ra10 is optionally substituted C1-6 alkyl (as defined above), C1-6 alkoxycarbonyl or C1-6 alkanoylamino and 1 is 0 or an integer of 1 to 6,
- (11) —ORa11
- wherein Ra11 is hydrogen atom or optionally substituted C1-6 alkyl (as defined above) or
- (12)
- 1373
- wherein
- ring B is
- (1′) C6-14 aryl,
- (2′) C3-8 cycloalkyl or
- (3′) heterocyclic group (as defined above),
- each Z is independently
- (1′) a group selected from the following group D,
- (2′) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the following group D,
- (3′) C3-8 cycloalkyl optionally substituted by 1 to 5 substituent(s) selected from the following group D,
- (4′) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the following group D,
- (5′) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the following group D,
- wherein the heterocyclic group has 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom, or
- (6′) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the following group D,
- wherein the heterocycle C1-6 alkyl is C1-6 alkyl substituted by heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the group D, as defined above,
- group D:
- (a) hydrogen atom,
- (b) halogen atom,
- (c) cyano,
- (d) nitro,
- (e) optionally substituted C1-6 alkyl (as defined above),
- (f) —(CH2)t—CORa18, (hereinafter each t means independently 0 or an integer of 1 to 6),
- wherein Ra18 is
- (1″) optionally substituted C1-6 alkyl (as defined above),
- (2″) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B or
- (3″) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B
- wherein the heterocyclic group has 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom,
- (g) —(CH2)t—COORa19
- wherein Ra19 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above) or C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (h) —(CH2)t—CONRa27 Ra28
- wherein Ra27 and Rs28 are each independently,
- (1″) hydrogen atom,
- (2″) optionally substituted C1-6 alkyl (as defined above),
- (3″) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (4″) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (5″) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (6″) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- wherein the heterocycle C1-6 alkyl is C1-6 alkyl substituted by heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B, as defined above,
- (7″) C3-8 cycloalkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (8″) C3-8 cycloalkyl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (9″) hydroxyl group or
- (10″) C1-6 alkoxy,
- (i) —(CH2)t—C(═NRa33)NH2
- wherein Ra33 is hydrogen atom, C1-6 alkyl, hydroxyl group or C1-6 alkoxy,
- (j) —(CH2)t—ORa20
- wherein Ra20 is
- (1″) hydrogen atom,
- (2″) optionally substituted C1-6 alkyl (as defined above),
- (3″) optionally substituted C2-6 alkenyl (as defined above),
- (4″) C2-6 alkynyl optionally substituted by 1 to 3 substituent(s) selected from the above group A,
- (5″) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (6″) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (7″) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (8″) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) 5 selected from the above group B,
- (9″) C3-8 cycloalkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B, or
- (10″) C3-8 cycloalkyl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (k) —(CH2)t—O—(CH2)p—CORa21
- wherein Ra21 is amino, C1-6 alkylamino or heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B, and p is 0 or an integer of 1 to 6,
- (l) —(CH2)t—NRa22Ra23
- wherein Ra22 and Ra23 are each independently
- (1″) hydrogen atom,
- (2″) optionally substituted C1-6 alkyl (as defined above),
- (3″) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (4″) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (5″) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B or
- (6″) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (m) —(CH2)t—NRa29CO—Ra24
- wherein Ra29 is hydrogen atom, C1-6 alkyl or C1-6 alkanoyl, and Ra24 is
- (1″) amino,
- (2″) C1-6 alkylamino,
- (3″) optionally substituted C1-6 alkyl (as defined above),
- (4″) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (5″) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B or
- (6″) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (n) —(CH2)t—NRa29SO2—Ra25
- wherein Ra29 is as defined above, and Ra25 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above), C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B or heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (o) —(CH2)t—S(O)q—Ra25
- wherein Ra25 is as defined above, and q is 0, 1 or 2,
- (p) —(CH2)t—SO2—NHRa26
- wherein Ra26 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above), C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B or heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B, and
- (q) heterocyclic group having 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom, and
- w is an integer of 1 to 3, and
- Y is
- (1′) a single bond,
- (2′) C1-6 alkylene,
- (3′) C2-6 alkenylene,
- (4′) —(CH2)m—O(CH2)n—, (hereinafter m and n are each independently 0 or an integer of 1 to 6),
- (5′) —CO—,
- (6′) —CO2—(CH2)n—,
- (7′) —CONH—(CH2)n—NH—,
- (8′) —NHCO2—,
- (9′) —NHCONH—,
- (10′) —O—(CH2)n—CO—,
- (11′) —O—(CH2)n—O—,
- (12′) —SO2—,
- (13′) —(CH2)m—NRa12—(CH2)n—
- wherein Ra12 is
- (1″) hydrogen atom,
- (2″) optionally substituted C1-6 alkyl (as defined above),
- (3″) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (4″) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (5″) —CORb5
- wherein Rb5 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above), C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B or C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (6″) —COORb5 (Rb5 is as defined above) or
- (7″) —SO2Rb5 (Rb5 is as defined above),
- (14′) —NRa12CO— (Ra12 is as defined above),
- (15′) —CONRa13—(CH2)n—
- wherein Ra13 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above) or C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (16′) —CONH—CHRa14—
- wherein Ra14 is C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (17′) —O—(CH2)m—CRa15Ra16—(CH2)n—
- wherein Ra15 and Ra16 are each independently
- (1″) hydrogen atom,
- (2″) carboxyl,
- (3″) C1-6 alkyl,
- (4″) —ORb6
- wherein Rb6 is C1-6 alkyl or C6-14 aryl C1-6 alkyl, or
- (5″) —NHRb7
- wherein Rb7 is hydrogen atom, C1-6 alkyl, C1-6 alkanoyl or C6-14 aryl C1-6 alkyloxycarbonyl, or Ra15 is optionally
- (6″)
- 1374
- wherein n′, ring B′, Z′ and w′ are the same as the above-mentioned n, ring B, Z and w, respectively, and may be the same as or different from the respective counterparts,
- (18′) —(CH2)n—NRa12—CHRa15— (Ra12 and Ra15 are each as defined above),
- (19′) —NRa17SO2—
- wherein Ra17 is hydrogen atom or C1-6 alkyl,
- (20′) —S(O)e—(CH2)m—CRa15Ra16—(CH2)n— (e is 0, 1 or 2, Ra15 and Ra16 are each as defined above), or
- (21′) —(CH2)m—CRa15Ra16—(CH2)n— (Ra15 and Ra16 are each as defined above).
A fused ring compound of the following formula [II]
- 1388
- wherein
- the moiety
- 1389
- is a fused ring selected from
- 1390
- wherein R1, R2, R3 and R4 are each independently,
- (1) hydrogen atom,
- (2) C1-6 alkanoyl,
- (3) carboxyl,
- (4) cyano,
- (5) nitro,
- (6) C1-6 alkyl optionally substituted by 1 to 3 substituent(s) selected from the following group A, group A;
- halogen atom, hydroxyl group, carboxyl, amino, C1-6 alkoxy, C1-6 alkoxy C1-6 alkoxy, C1-6 alkoxycarbonyl and C1-6 alkylamino,
- (7) —COORa1
- wherein Ra1 is optionally substituted C1-6 alkyl (as defined above), C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the following group B or glucuronic acid residue, group B;
- halogen atom, cyano, nitro, C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkanoyl, —(CH2)r—COORb1, —(CH2)r—CONRb1Rb2, —(CH2)r—NRb1Rb2, —(CH2)r—NRb1—CORb2, —(CH2)r—NHSO2Rb1, —(CH2)r—ORb1, —(CH2)r—SRb1, —(CH2)r—SO2Rb1 and —(CH2)r—SO2NRb1Rb2
- wherein Rb1 and Rb2 are each independently hydrogen atom or C1-6 alkyl and r is 0 or an integer of 1 to 6,
- (8) —CONRa2Ra3
- wherein Ra2 and Ra3 are each independently hydrogen atom, C1-6 alkoxy or optionally substituted C1-6 alkyl (as defined above),
- (9) —C(═NRa4)NH2
- wherein Ra4 is hydrogen atom or hydroxyl group,
- (10) —NHRa5
- wherein Ra5 is hydrogen atom, C1-6 alkanoyl or C1-6 alkylsulfonyl,
- (11) —ORa6
- wherein Ra6 is hydrogen atom or optionally substituted C1-6 alkyl (as defined above),
- (12) —SO2Ra7
- wherein Ra7 is hydroxyl group, amino, C1-6 alkyl or C1-6 alkylamino,
- (13) —P(═O)(ORa31)2
- wherein Ra31 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above) or C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B, or
- (14) heterocyclic group having 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom, and
- R7 is hydrogen atom or optionally substitute C1-6 alkyl (as defined above),
- ring Cy′ is
- (1) C3-8 cycloalkyl optionally substituted by 1 to 5 substituent(s) selected from the following group C, group C;
- hydroxyl group, halogen atom, C1-6 alkyl and C1-6 alkoxy, or
- (2)
- 1391
- wherein u and v are each independently an integer of 1 to 3,
- ring A′ is a group selected from a group consisting of phenyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, cyclohexyl, cyclohexenyl, furyl and thienyl, R5′ and R6′ are each independently
- (1) hydrogen atom,
- (2) halogen atom,
- (3) optionally substituted C1-6 alkyl (as defined above) or
- (4) hydroxyl group
- ring B is
- (1) C6-14 aryl,
- (2) C3-8 cycloalkyl or
- (3) heterocyclic group having 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom,
- each Z is independently
- (1) a group selected from the following group D,
- (2) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the following group D,
- (3) C3-8 cycloalkyl optionally substituted by 1 to 5 substituent(s) selected from the following group D,
- (4) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the following group D,
- (5) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the following group D wherein the heterocyclic group has 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom, or
- (6) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the following group D wherein the heterocycle C1-6 alkyl is C1-6 alkyl substituted by heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the group D, as defined above,
- group D:
- (a) hydrogen atom,
- (b) halogen atom,
- (c) cyano,
- (d) nitro,
- (e) optionally substituted C1-6 alkyl (as defined above),
- (f) —(CH2)t—CORa18, (hereinafter each t means independently 0 or an integer of 1 to 6),
- wherein Ra18 is
- (1′) optionally substituted C1-6 alkyl (as defined above),
- (2′) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B or
- (3′) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B
- wherein the heterocyclic group has 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom,
- (g) —(CH2)t—COORa19
- wherein Ra19 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above) or C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (h) —(CH2)t—CONRa27Ra28
- wherein Ra27 and Ra28 are each independently,
- (1′) hydrogen atom,
- (2′) optionally substituted C1-6 alkyl (as defined above),
- (3′) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (4′) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (5′) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (6′) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- wherein the heterocycle C1-6 alkyl is C1-6-alkyl substituted by heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B, as defined above,
- (7′) C3-8 cycloalkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (8′) C3-8 cycloalkyl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (9′) hydroxyl group or
- (10′) C1-6 alkoxy,
- (i) —(CH2)t—C(═NRa33)NH2
- wherein Ra33 is hydrogen atom, C1-6 alkyl, hydroxyl group or C1-6 alkoxy,
- (j) —(CH2)t—ORa20
- wherein Ra20 is
- (1′) hydrogen atom,
- (2′) optionally substituted C1-6 alkyl (as defined above),
- (3′) optionally substituted C2-6 alkenyl (as defined above),
- (4′) C2-6 alkynyl optionally substituted by 1 to 3 substituent(s) selected from the above group A,
- (5′) C614 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (6′) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (7′) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (8′) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (9′) C3-8 cycloalkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B, or
- (10′) C3-8 cycloalkyl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (k) —(CH2)t—O—(CH2)p—CORa21
- wherein Ra21 is amino, C1-6 alkylamino or heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- and p is 0 or an integer of 1 to 6,
- (l) —(CH2)t—NRa22Ra23
- wherein Ra22 and Ra23 are each independently
- (1′) hydrogen atom,
- (2′) optionally substituted C1-6 alkyl (as defined above),
- (3′) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (4′) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (5′) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B or
- (6′) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (m) —(CH2)t—NRa29CO—Ra24
- wherein Ra29 is hydrogen atom, C1-6 alkyl or C1-6 alkanoyl, and Ra24 is
- (1′) amino,
- (2′) C1-6 alkylamino,
- (3′) optionally substituted C1-6 alkyl (as defined above),
- (4′) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (5′) heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B, or
- (6′) heterocycle C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (n) —(CH2)t—NRa29SO2—Ra25
- wherein Ra29 is as defined above, and Ra25 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above), C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B or heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (o) —(CH2)t—S(O)q—Ra25
- wherein Ra25 is as defined above, and q is 0, 1 or 2,
- (p) —(CH2)t—SO2—NHRa26
- wherein Ra26 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above), C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B or heterocyclic group optionally substituted by 1 to 5 substituent(s) selected from the above group B, and
- (q) heterocyclic group having 1 to 4 heteroatom(s) selected from an oxygen atom, a nitrogen atom and a sulfur atom,
- w is an integer of 1 to 3, and
- Y is
- (1) a single bond,
- (2) C1-6 alkylene,
- (3) C2-6 alkenylene,
- (4) —(CH2)m—O—(CH2)n—, (hereinafter m and n are each independently 0 or an integer of 1 to 6),
- (5) —CO—,
- (6) —CO2—(CH2)n—,
- (7) —CONH—(CH2)n—NH—,
- (8) —NHCO2—,
- (9) —NHCONH—,
- (10) —O—(CH2)n—CO—,
- (11) —O—(CH2)n—O—,
- (12) —SO2—,
- (13) —(CH2)m—NRa12—(CH2)n—
- wherein Ra12 is
- (1′) hydrogen atom,
- (2′) optionally substituted C1-6 alkyl (as defined above),
- (3′) C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (4′) C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (5′) -CORb5
- wherein Rb5 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above), C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B or C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (6′) —COORb5 (Rb5 is as defined above) or
- (7′) —SO2Rb5 (Rb5 is as defined above),
- (14) —NRa12CO— (Ra12 is as defined above),
- (15) —CONRa13—(CH2)n—
- wherein Ra13 is hydrogen atom, optionally substituted C1-6 alkyl (as defined above) or C6-14 aryl C1-6 alkyl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (16) —CONH—CHRa14—
- wherein Ra14 is C6-14 aryl optionally substituted by 1 to 5 substituent(s) selected from the above group B,
- (17) —O—(CH2)n—CRa15Ra16—(CH2)n—
- wherein Ra15 and Ra16 are each independently
- (1′) hydrogen atom,
- (2′) carboxyl,
- (3′) C1-6 alkyl,
- (4′) ORb6
- wherein Rb6 is C1-6 alkyl or C6-14 aryl C1-6 alkyl, or
- (5′) NHRb7
- wherein Rb7 is hydrogen atom, C1-6 alkyl, C1-6 alkanoyl or C6-14 aryl C1-6 alkyloxycarbonyl, or Ra15 is optionally
- (6′)
- 1392
- wherein n′, ring B′, Z′ and w′ are the same as the above-mentioned n, ring B, Z and w, respectively, and may be the same as or different from the respective counterparts,
- (18) —(CH2)n—NRa12—CHRa15— (Ra12 and Ra15 are each as defined above),
- (19) —NRa17SO2—
- wherein Ra17 is hydrogen atom or C1-6 alkyl,
- (20) —S(O)e—(CH2)m—CRa15Ra16—(CH2)n— (e is 0, 1 or 2, Ra15 and Ra16 are each as defined above), or
- (21) —(CH2)m—CRa15Ra16—(CH2)n— (Ra15 and Ra16 are each as defined above),
- or a pharmaceutically acceptable salt thereof.
A benzimidazole compound of the following formula [III]
- 1401
- wherein Ra36 is hydrogen atom or carboxyl-protecting group, Ra37 is cyclopentyl or cyclohexyl, and Ra38 is hydrogen atom or fluorine atom, or a salt thereof.
A thiazole compound selected from the group consisting of 4-(4-fluorophenyl)-5-hydroxymethyl-2-methylthiazole and 4-(4-fluorophenyl)-5-chloromethyl-2-methylthiazole, or a pharmaceutically acceptable salt thereof.
A biphenyl compound selected from the group consisting of 1-(4′-chloro-2-hydroxymethyl-biphenyl-4-yl)-2-pyrrolidinone and 1-(4′-chloro-2-chloromethyl-biphenyl-4-yl)-2-pyrrolidinone, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.